此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

A Community-Based Chronic Pain Self-Management Program in West Virginia

2021年4月9日 更新者:Dina L Jones, PT, PhD、West Virginia University

A Randomized Controlled Trial of a Community-Based Chronic Pain Self-Management Program in West Virginia

Chronic pain (CP) affects 1 in 3 US adults and costs up to $635 billion annually in medical costs and lost work productivity. Use of opioid medications for CP has risen in the US, and opioid overdose deaths have quadrupled, yet with no overall change in pain. Although one-third of US adults have CP, there is a lack of affordable, non-pharmacological, evidence-based, community-delivered interventions for people with CP.

One program, the Chronic Pain Self-Management Program (CPSMP), provides short-term improvements in pain but its long-term effects have not been evaluated. This study will examine the long-term effects of CPSMP in the medically underserved state of West Virginia (WV). The objectives of this community-engaged, randomized, wait-list controlled study are to: 1) determine the short- (26 weeks) and long-term (52 weeks) effectiveness of the 6-week CPSMP in adults with CP in WV; 2) evaluate the Reach (number of participants, completers), Effectiveness (outcomes), Adoption (number of sites, leaders, trainings), Implementation (fidelity), and Maintenance (satisfaction, continuation) of CPSMP using the RE-AIM Framework; and 3) disseminate the results to key stakeholders including evidence-based organizations, public health practitioners/researchers, and healthcare providers.

The study will enroll 240 participants in 24 workshops at 12 community-based sites in 2 counties in WV, Greenbrier (rural) and Wood (urban). Participants will attend free, 2.5-hour weekly sessions for 6 weeks. Self-reported, performance-based, and physiological data will be collected at baseline and 26, and 52 weeks after the start of the intervention. The primary outcomes are pain (severity, quality, interference, medication use), mental health (mood, anxiety, catastrophizing), function (self-efficacy, coping, health-related quality of life, sleep, fatigue, communication, physical activity), healthcare utilization, missed work days, and gait speed.

研究概览

详细说明

Chronic pain (CP) affects 1 in 3 US adults and costs up to $635 billion annually in medical costs and lost work productivity. The impact of CP is worse in people with both CP and comorbid chronic diseases such as arthritis, diabetes, and heart disease. Use of opioid medications for CP has risen in the US, and opioid overdose deaths have quadrupled, yet with no overall change in pain. Although one-third of US adults have CP, there is a lack of affordable, non-pharmacological, evidence-based, community-delivered interventions for people with CP. Thus, there is a vital need to rigorously test more interventions that can be brought to scale and widely disseminated in the US.

One program, the Chronic Pain Self-Management Program (CPSMP), provides short-term improvements in pain but its long-term effects have not been evaluated. This study will examine the long-term effects of CPSMP in the medically underserved state of West Virginia (WV). With one of the worst health profiles in the US, WV has the highest rates of arthritis, diabetes, heart disease, and drug overdose deaths, and therefore has a compelling need for the CPSMP. The objectives of this community-engaged, randomized, wait-list controlled study are to: 1) determine the short- (26 weeks) and long-term (52 weeks) effectiveness of the 6-week CPSMP in adults with CP in WV; 2) evaluate the Reach (number of participants, completers), Effectiveness (outcomes), Adoption (number of sites, leaders, trainings), Implementation (fidelity), and Maintenance (satisfaction, continuation) of CPSMP using the RE-AIM Framework; and 3) disseminate the results to key stakeholders including evidence-based organizations, public health practitioners/researchers, and healthcare providers.

The study will enroll 240 participants in 24 workshops at 12 community-based sites in 2 counties in WV, Greenbrier (rural) and Wood (urban). Participants will attend free, 2.5-hour weekly sessions for 6 weeks. Two trained leaders will facilitate group discussions on managing pain, emotions, depression, fatigue, and sleep; proper exercise, nutrition, and medication use; weight management; strategies for effective communication with healthcare professionals; evaluating treatments; and pacing/planning. Self-reported, performance-based, and physiological data will be collected at baseline and 26, and 52 weeks after the start of the intervention. The primary outcomes are pain (severity, quality, interference, medication use), mental health (mood, anxiety, catastrophizing), function (self-efficacy, coping, health-related quality of life, sleep, fatigue, communication, physical activity), healthcare utilization, missed work days, and gait speed.

研究类型

介入性

注册 (实际的)

196

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • West Virginia
      • Lewisburg、West Virginia、美国、24901
        • West Virginia School of Osteopathic Medicine
      • Parkersburg、West Virginia、美国、26101
        • Mid-Ohio Valley Health Department

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Adults over age 18
  • Have chronic pain (pain on most days or everyday) for the past 3 months or more
  • Able to attend 1 CPSMP workshop a week over 6 weeks
  • Able to attend 3-4 testing sessions for data collection (testing sessions are scheduled before the workshops begin and then six months, one year and, for those assigned to the control group, one and a half years after the start of the study)

Exclusion Criteria:

  • Chronic pain caused by current cancer diagnosis or an open wound
  • Lack reliable transportation
  • Having surgery for the painful area in the next year
  • Not community-dwelling (i.e., living in a nursing home, assisted living or personal care home, mental hospital, or correctional facility)
  • Not willing to be randomized to either start CPSMP workshop now or in six months
  • Participation in another self-management program (e.g., Diabetes Self-Management Program) in the past 12 months
  • Unable to speak English

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:其他
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:CPSMP Intervention
Participants randomly assigned to this arm will, following a baseline assessment, immediately begin attending a 6-week Chronic Pain Self-Management Program (CPSMP) workshop.
Stanford University's Chronic Pain Self-Management Program (CPSMP) was developed by Sandra LeFort in 1996 and based on Stanford's Arthritis Self-Management Program and the Chronic Disease Self-Management Program. The 6-week community-delivered workshop consists of 2.5-hour weekly sessions for people with a primary or secondary diagnosis of Chronic Pain.
有源比较器:Wait-list Control Group
Participants assigned to this arm will wait six months after a baseline assessment and then attend the 6-week Chronic Pain Self-Management Program (CPSMP) workshop.
Stanford University's Chronic Pain Self-Management Program (CPSMP) was developed by Sandra LeFort in 1996 and based on Stanford's Arthritis Self-Management Program and the Chronic Disease Self-Management Program. The 6-week community-delivered workshop consists of 2.5-hour weekly sessions for people with a primary or secondary diagnosis of Chronic Pain.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Pain severity
大体时间:Change between baseline and 52 weeks
Using Stanford's 0-10 Pain Visual Numeric Scale participants will rate their pain in the past 2 weeks on an 11-item scale ranging from 0 (no pain) to 10 (severe pain).
Change between baseline and 52 weeks
Defense and Veterans Pain Rating Scale
大体时间:Change between baseline and 52 weeks
Using the Defense and Veterans Pain Rating Scale will rate their pain in the past 2 weeks on an 11-item scale ranging from 0 (no pain) to 10 (severe pain).
Change between baseline and 52 weeks

次要结果测量

结果测量
措施说明
大体时间
Pain interference with sleep
大体时间:Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Defense and Veterans Pain Rating Scale Supplemental Question (revised from 24 hours to past 2 weeks)
Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Pain frequency
大体时间:Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
2016 NHIS (past 3 months)
Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Perceived disability
大体时间:Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Pain Disability Index
Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Pain avoidance
大体时间:Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Tampa Scale of Kinesiophobia. A total score is calculated that ranges from 17 (low degree of kinesiophobia) to 68 (a high degree of kinesiophobia)
Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Opioid misuse
大体时间:Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Screener and Opioid Assessment for Patients with Pain (SOAPP) v1.0-SF
Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Medication Usage
大体时间:Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Morphine milligram equivalents (MME) per day of current prescription or over-the-counter medications for pain, depression, anxiety, mood, or sleep (also usage of stimulants and muscle relaxers)
Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Mood
大体时间:Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Stanford Personal Health Questionnaire-Depression (PHQ-8)
Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Anxiety
大体时间:Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Generalized Anxiety Disorder-7 (GAD-7)
Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Catastrophizing
大体时间:Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Pain Catastrophizing Scale. The total score ranges from 0 (low catastrophizing) to 52 (high catastrophizing). There are 3 subscales (rumination, magnification, and helplessness)
Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Mindfulness
大体时间:Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
5 Facet Mindfulness Questionnaire Short Form
Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Pain Self-Efficacy
大体时间:Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Pain Self-Efficacy Scale. The total score ranges from 0 (low self-efficacy) to 60 (high self-efficacy)
Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Coping
大体时间:Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Coping Strategies Questionnaire-Revised
Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Activation
大体时间:Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Patient Activation Measure
Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
General Health Status
大体时间:Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
2016 BRFSS question
Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Vitality
大体时间:Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
SF-36 v1
Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Minutes of Physical Activity
大体时间:Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
2016 NHIS questions
Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
Healthcare Utilization
大体时间:Monthly for up to 12 months
Emergency room visits and doctor/clinic visits
Monthly for up to 12 months
Work
大体时间:Monthly for up to 12 months
Number of days missed work and number of days in bed more than half of the day
Monthly for up to 12 months
Gait speed
大体时间:Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.
5- or 10-meter gait speed test
Data will be collected at baseline, 26 weeks after the start of the study and 52 weeks after the study start.

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2018年6月18日

初级完成 (实际的)

2021年4月9日

研究完成 (实际的)

2021年4月9日

研究注册日期

首次提交

2018年6月14日

首先提交符合 QC 标准的

2018年6月27日

首次发布 (实际的)

2018年7月11日

研究记录更新

最后更新发布 (实际的)

2021年4月12日

上次提交的符合 QC 标准的更新

2021年4月9日

最后验证

2021年4月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • 3U48DP005004-04S1 (美国 NIH 拨款/合同)

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅